Nanovalent Pharmaceuticals Inc
NanoValent Pharmaceuticals Inc, based in Bozeman, MT, is a privately held biotechnology company focused on developing innovative therapeutic solutions, particularly in the field of cancer treatment. The company has established a unique NANOADC-like targeted nanosphere platform, which aims to enhance the delivery, safety, and performance of both existing and emerging therapeutics, including antibody-drug conjugates (ADCs).
Collaborating closely with Children's Hospital Los Angeles and other academic partners, NanoValent is advancing its lead product, NV103, which is approaching Investigational New Drug (IND) status and is expected to enter clinical trials in 2026. The company is currently seeking Series A financing in 2025 and is supported by a highly experienced management team with a proven track record in the industry.
Generated from the website
Also at this address
You might also like
Partial Data by Infogroup (c) 2025. All rights reserved.

